Published December 31, 2023 | Version v1
Journal article Open

Cerebral Mucormycosis without Rhino-Orbital Involvement in a Patient with Chronic Kidney Disease

Description

Isolated cases of cerebral mucormycosis demand high clinical suspicion and prompt diagnosis and treatment. In the present case, the patient was a young diagnosed case of chronic kidney disease (CKD) for two years on maintenance hemodialysis, presented with symptoms of headache and increased intracranial pressure, which necessitated both emergency surgical and medical management and was both diagnosed and managed efficiently. Early recognition of clinical and radiological cues with early institution of a medico-surgical approach, with proper containment of underlying predisposing conditions, is vital for managing mucormycosis. The case elucidates that mucormycosis can present as an isolated cerebral abscess without rhino-orbital involvement. CKD should be considered as a possible immunocompromised state predisposing to mucormycosis.

Files

Cerebral Mucormycosis without Rhino-Orbital Involvement in a Patient with Chronic Kidney Disease.pdf

Additional details

Dates

Accepted
2023-12-31
Published

References

  • 1. Prakash H, Chakrabarti A. Global Epidemiology of Mucormycosis. J Fungi (Basel). 2019;5(1):26.
  • 2. Meyerowitz EA, Sanchez S, Mansour MK, Triant VA, Goldberg MB. Isolated Cerebral Mucormycosis in Immunocompetent Adults who Inject Drugs: Case Reports and Systematic Review of the Literature. Open Forum Infect Dis. 2020;7(12):ofaa552.
  • 3. Syed-Ahmed M, Narayanan M. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2019;26(1):8-15.
  • 4. Collins AJ, Kasiske B, Herzog C, et al. Excerpts from the United States Renal Data System 2003 Annual Data Report: atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2003;42(6 Suppl 5): A5-S230.
  • 5. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012;54 Suppl 1:S23-S34.
  • 6. Skiada A, Lass-Floerl C, Klimko N, Ibrahim A, Roilides E, Petrikkos G. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol. 2018;56(suppl_1):93-101.
  • 7. Farmakiotis D, Kontoyiannis DP. Mucormycoses. Infect Dis Clin North Am. 2016;30(1):143-63.
  • 8. Betjes MG, Litjens NH. Chronic kidney disease and premature ageing of the adaptive immune response. Curr Urol Rep. 2015;16(1):471.
  • 9. Skiada A, Pavleas I, Drogari-Apiranthitou M. Epidemiology and Diagnosis of Mucormycosis: An Update. J Fungi (Basel). 2020;6(4):265.
  • 10. Goel K, Dhillon J, Yadav V, Bhagat S, Aggarwal A. Post-Covid Isolated Mandibular Mucormycosis in a Patient with Chronic Kidney Disease: A Case Report. Indian J Otolaryngol Head Neck Surg. Published online April 29, 2023.
  • 11. Cuellar H, Riascos R, Palacios E, Rojas R, Molina P. Imaging of isolated cerebral mucormycosis. A report of three cases. Neuroradiol J. 2007;20(5):525-30.
  • 12. Escobar A, Del Brutto OH. Multiple brain abscesses from isolated cerebral mucormycosis. J Neurol Neurosurg Psychiatry. 1990;53(5):431-3.
  • 13. Dadwal SS, Kontoyiannis DP. Recent advances in the molecular diagnosis of mucormycosis. Expert Rev Mol Diagn. 2018;18(10):845-54.
  • 14. Millon L, Caillot D, Berceanu A, et al. Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial. Clin Infect Dis. 2022;75(5):777-85.
  • 15. Khapuinamai A, Sharma S, Dave TV, Kapoor AG, Joseph J. Molecular diagnosis of rhino-orbital mucormycosis in a COVID-19 setting. Int Ophthalmol. 2023;43(6):1803-10.
  • 16. Shankar R, Tyagi AK, Panda PK, Madaan S, Jeladharan R, Kaistha N. Deadly dual fungal infections in a chronic kidney disease patient. J Med Evid. 2021;2:30-3.